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wild populations
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Mätz-Rensing3, Kathrin Nowak1,9, Sonja Metzger4,10, John Kiyang5, Antina Lübke Becker6, 
Tobias Deschner4, Roman M. Wittig4,7, Felix Lankester  5,8 & Fabian H. Leendertz1
Habituation of wild great apes for tourism and research has had a significant positive effect on the 
conservation of these species. However, risks associated with such activities have been identified, 
specifically the transmission of human respiratory viruses to wild great apes, causing high morbidity 
and, occasionally, mortality. Here, we investigate the source of bacterial-viral co-infections in wild and 
captive chimpanzee communities in the course of several respiratory disease outbreaks. Molecular 
analyses showed that human respiratory syncytial viruses (HRSV) and human metapneumoviruses 
(HMPV) were involved in the etiology of the disease. In addition our analysis provide evidence for 
coinfection with Streptococcus (S.) pneumoniae. Characterisation of isolates from wild chimpanzees 
point towards a human origin of these bacteria. Transmission of these bacteria is of concern because – in 
contrast to HRSV and HMPV - S. pneumoniae can become part of the nasopharyngeal flora, contributing 
to the severity of respiratory disease progression. Furthermore these bacteria have the potential to 
spread to other individuals in the community and ultimately into the population. Targeted vaccination 
programs could be used to vaccinate habituated great apes but also human populations around great 
ape habitats, bringing health benefits to both humans and wild great apes.
Due to their close genetic relationship, humans and other great apes share susceptibility to a consider-
able number of pathogens1,2 with the transmission of human respiratory pathogens to captive apes being 
a well-documented concern3–11. In this context, it had been long suspected that pathogen transmission from 
humans might account for disease outbreaks observed in wild great apes habituated to human presence for 
research and tourism7,12–14. This suspicion was confirmed when common human respiratory paramyxoviruses 
(human respiratory syncytial virus (HRSV) and human metapneumovirus (HMPV)) were identified in chimpan-
zee (Pan troglodytes verus) lung tissue and faeces collected during separate disease outbreaks in Taï National Park 
(Côte d’Ivoire)15,16. Further studies on wild chimpanzees in Tanzania (Pan troglodytes schweinfurthii) and gorillas 
(Gorilla beringei) in Rwanda and the Central African Republic have demonstrated additional incidences in which 
human respiratory paramyxoviruses have been transmitted to great apes indicating that these events are neither 
isolated nor a feature of a particular region (Table 1)17–19.
In addition to human viruses, the bacterium Streptococcus pneumoniae (or pneumococcus) was also detected 
during outbreaks where samples of lung tissue had been collected15,18,20, leading to the conclusion that it was the 
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combination of respiratory viruses and pneumococci, and not the viral infection alone, that caused the fatali-
ties15,16. Given that invasive pneumococcal infections are also a primary cause of severe pneumonia in humans 
worldwide21,22, these bacterial co-infections are a cause for concern since they could lead to increased mortality 
and persist in the great ape populations.
However the provenance of the pneumococci strains from the great ape cases mentioned above remains 
uncertain. Sequence analyses have so far only been performed on S. pneumoniae positive chimpanzee samples 
from Taï National Park and these showed differences to known human sequences20,23. Unfortunately, there is a 
lack of data on regional human pneumococci sequence types and therefore transmission from humans could not 
be confirmed20.
In this article we investigate respiratory disease outbreaks causing mortalities among wild and captive 
wild-borne great apes in West and western-Central Africa. Again, HRSV and HMPV were detected together with 
pneumococci and we provide evidence that all were of human origin. These results are important since, in con-
trast to human respiratory viruses, pneumococci may become an established part of the great ape oropharyngeal 
flora and could severely impact the outcome of subsequent respiratory infections or, as in humans, become the 
primary cause of severe pneumonia.
Results and Discussion
Samples were collected in the course of several respiratory disease outbreaks that occurred at two different loca-
tions: in the Limbe Wildlife Center (LWC) situated in Cameroon, and in Taï National Park (TNP), Côte d’Ivoire.
The LWC is a wildlife rehabilitation project in which rescued great apes are kept in naturalistic enclosures. 
Here, a total of five distinct outbreaks of respiratory disease occurred over a period of two years (2006/2007), in 
three separate chimpanzee groups (see Table 1): group 1 consisted of 22 individuals (age >5years), group 2 of 
14 individuals between two and five years of age and group 3 consisted of four individuals of less than two years 
of age. The chimpanzees showed varying clinical symptoms (coughing, serous to mucopurulent nasal discharge, 
lethargy, inappetence) over the course of the outbreaks. Symptoms indicative of lower respiratory tract infection, 
such as dyspnoea and wheezing sounds, were noted on auscultation of the lungs of 12 individuals. Duration of 
the outbreaks ranged from several days up to nine weeks. Morbidity ranged from 23 to 100% (with 100% in three 
of the five outbreaks; see Table 1). During these outbreaks pharyngeal swabs from six chimpanzees were taken 
under anesthesia. During one outbreak an infant chimpanzee (referred to as LWC infant) died, a necropsy was 
performed and tissue samples were taken. Throughout the outbreaks, animals with severe symptoms were placed 
on antiobiotic therapy (see Supplementary Information).
In TNP, wild chimpanzees are habituated to the presence of human observers and individually known as a 
result of a project focusing on wild chimpanzee behaviour24. Here, three chimpanzee communities (so called 
North, East and South community) are under observation. In November 2009 the South community was affected 
by a respiratory disease outbreak. Morbidity and mortality were high: 32/37 chimpanzees developed severe 
respiratory symptoms (including high frequency of heavy cough, lethargy, nasal discharge). Four adults (>15 
years; hereinafter referred to as TNP adult 1–4) and two infants (0–5 years, referred to as TNP infant 1 and 2) 
were found shortly after death and necropsies were performed. In addition, for one chimpanzee (adult) only 
one arm and the head was found due to scavenging. Four infants were found dead but necropsies were not per-
formed and three further adults disappeared in the course of the outbreak and are likely victims of the outbreak 
as well. In total likely 8 adults and 6 infant chimpanzees died in this outbreak. Twelve out of the 37 individuals 
who showed severe symptoms of respiratory disease were treated with Extencilline (Benzathine benzylpenicil-
lin, Sanofi-Aventis France), a long acting antibiotic administered by remote injection. Of these nine survived.
Histopathology. Histopathological examination of lung tissue samples from TNP and LWC chimpanzees 
revealed a severe purulent bronchopneumonia as cause of disease. The bronchoalveolar tissue was diffusely infil-
trated with neutrophilic granulocytes and macrophages. Furthermore, all lung tissue samples collected during the 
TNP outbreak showed multinucleated cell syncytia, pointing towards an HRSV infection (Fig. 1). Additionally, 
gram-positive cocci could be demonstrated within the altered tissue giving evidence for a secondary bacterial 
infection. In addition, the lung tissue of one animal (TNP adult 3) revealed signs of a lung mite infection (likely 
Pneumonyssus simicola). The lung tissue from the LWC infant showed a multifocal to diffuse purulent bron-
chopneumonia with marginal alveolar histiocytosis. The periodic acid schiff (PAS) reaction was negative for all 
samples excluding a fungal infection.
Molecular analysis. All samples collected from the TNP and LWC outbreaks were analysed molecularly 
by screening PCR and tested positive for either HMPV- or HRSV-specific genes as well as for the lytA gene har-
boured by S. pneumoniae (see Table 1). Phylogenetic analyses of generated paramyxovirus sequences revealed that 
both HRSV and HMPV sequences (Genbank accession no. JX489496- JX489498) belonged to recent pandemic 
waves (see Supplementary Figs 1–3). Informing a relaxed molecular clock model with tip dates25 we estimated 
that the LWC chimpanzee-infecting HMPV diverged from its closest human-infecting relatives in 2004 (95% 
highest posterior density: 2003–2004). The date of divergence between the HRSV-A strain from TNP chimpan-
zees and humans was 2007 (95% highest posterior density: 2006–2008) and for HRSV-B strains infecting LWC 
chimpanzees and humans 2007 (95% highest posterior density: 2007) These results mirror findings from previ-
ous outbreaks15–19 and emphasize the high incidence of anthropozoonotic transmission of human respiratory 
paramyxoviruses.
In order to gain new insights on the bacterial community present in the lung samples collected during the 
outbreak in TNP, we performed 16S rRNA PCR. Characterization of the sequences using a BLAST search in 
GenBank indicated the presence of Streptococcus species in all samples analysed. In addition, for one individ-
ual (TNP adult 3) Pasteurella (P.) multocida was also among the predominant BLAST hits. P. multocida is a 
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commensal in the upper respiratory tracts of many domestic and wild animal species worldwide and coinfection 
with P. multocida and S. pneumoniae among TNP chimpanzees has been reported previously16,20,26. In addition, 
for the samples from TNP adult 1, the BLAST search revealed Clostridium sp. Since most species of the genus 
Clostridium are saprophytic, we conclude that this finding was due to the tissue samples being partly decayed.
Molecular analysis of the S. pneumoniae is considered separately in the next section.
phenotypic and molecular characterisation of S. pneumoniae. Isolation of pneumococci was 
achieved for TNP adult 1 and 2 (isolate IMT 113 and 115) from whom lung tissue samples had been stored ade-
quately in Skim Milk-Tryptone-Glucose-Glycerol (STGG). Antibiotic susceptibility testing (Table 2) showed low 
resistance: isolates were resistant against sulfamethoxazole/trimethoprim (TMP-SMX) only. Further characteri-
sation by Multi Locus Sequence Typing (MLST, see Table 3) indicated that alleles from isolates termed IMT 113 
and 115 were identical and matched known alleles from human strains. Their allelic profile revealed 6 matches 
to various published serotype 19 A strains from Kenya and the Gambia (>100 isolates) but harbour a variant ddl 
allele. Therefore a new sequence type (ST 8485) was assigned (see Table 2). Serotyping of the TNP samples by 
PCR also revealed capsular type 19 A.
Lung samples from the LWC infant had not been stored adequately for cultivation. Therefore, a full DNA 
extract of this sample was used for further characterization. Hence, MLST results are based on “virtual clones” 
(see methods). For the LWC sample all seven alleles matched known alleles from human strains and indeed, 
allelic profiles were identical to a serotype 9 V strain isolated from a human of African origin (see Table 2). DNA 
from the LWC sample was tested for capsular type 9 V27 but tested negative. In addition we tried another 9 V/9 A 
primer combination described by Carvalho et al.28 but again the DNA tested negative. Unfortunately due to lack 
of DNA material it was not possible to test for further serotypes.
In summary, the MLST profiles of the strains described here showed high similarities or were even identical to 
human isolates, especially in Africa. In addition, results from the antibiotic susceptibility testing (Table 2) showed 
that the isolates from TNP chimpanzees were resistant to TMP-SMX. Resistance to TMP-SMX, which has been 
used widely in developing countries, is observed frequently and globally in human strains of S. pneumoniae29. The 
fact that this drug has never been used in the chimpanzees of TNP supports the assumption that the S. pneumo-
niae strain found originated in humans.
S. pneumoniae infection, especially in combination with respiratory viruses, can lead to invasive lower respira-
tory disease with fatal outcomes. Furthermore, and in contrast to respiratory virus infections, which are usually 
temporary, S. pneumonia infection in humans can result in an asymptomatic colonization of the nasopharynx. 
Additionally this bacterium can spread horizontally and remain silent within a population30. In fact, pneumococ-
cal disease in humans will not occur without preceding nasopharyngeal colonization30, hence an increased rate 
of colonization within a population will increase the incidence of invasive pneumococcal disease. To investigate 
Figure 1. (a,b) Histopathology from lung of a chimpanzee from TNP, purulent bronchopneumonia. (1a) 
overview showed parts of a bronchus in the lower left and lung alveoli completely filled with exudate. Scale bare 
400 µm. (1b) The exudate in the alveoli (asterisk) is composed of neutrophilic granulocytes, histiocytes and 
fibrin, the arrow points on cell syncytia, scale bar 100 µm. Hematoxylin and Eosin stain.
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whether the TNP chimpanzee population are ‘carriers’ of S. pneumoniae, we investigated a throat swab obtained 
in 2011 during a necropsy on an adult female chimpanzee living in TNP (named “XENA”; East group). This 
chimpanzee had died from an anthrax-like disease31 independent of any respiratory disease outbreak. Since no 
isolate of S. pneumoniae could be obtained, we tested full DNA for the presence of the new variant of the capsule 
3 (cps3Taï) described in chimpanzees that died between 2004 and 200623 and performed MLST analyses. Indeed, 
the sample was positive for cps3Taï. MLST revealed several sequences with close matches to S. pneumoniae but 
also S. oralis and S. mitis. The finding of mixed sequences of oral commensal bacteria was not unexpected since 
we used a throat swab (instead of a pure culture of S. pneumoniae) for examination. However, exact matches to all 
sequences characterizing the ‘South clone’ ST 2309 (found in the lung tissue of deceased TNP chimpanzees which 
died in respiratory disease outbreaks in TNP in 2004 and 2006), have been amongst the sequences obtained. This 
provides preliminary evidence that this ST may have circulated within the chimpanzee community for at least 
five years.
Conclusion
Here we provide the first evidence that S. pneumoniae can be transmitted and that the origin of this pathogen 
might be human. S. pneumoniae has the potential to circulate over long periods of time in a given population 
(a finding supported by our data on the chimpanzee XENA) and may cause severe disease once an individual is 
weakened by further primary viral infections or through other circumstances30,32. Given that adolescent female 
chimpanzees migrate to other communities and that other inter-troop encounters occur, the reported findings 
could have serious implications, not only in respect to the clinical outcome of individuals infected, but also for 
populations of wild chimpanzees33. In addition, the risk of ex-captive chimps transmitting human S. pneumoniae 
into wild populations is a serious concern for reintroduction programs.
These results underline the importance of hygiene measures, as established in TNP and described in the new 
IUCN guidelines, in limiting the risk of pathogen transmission between humans and great apes34. Moreover these 
results underscore the importance of developing non-invasive sample collection methods to assess the risk of the 
spread of such pathogens to wild chimpanzee and other great ape communities. We note that, characterisation 
of S. pneumoniae present in human communities in contact to or neighbouring wild great ape populations are 
needed to allow further conclusions regarding naturally occurring, and introduced, infections. Given the avail-
ability of vaccines that provide protection against the serotypes most frequently associated with pneumococcal 
disease in humans, characterisation of the distribution of serotypes would be of great interest. Such data will 
inform the design of vaccination campaigns targeting human-habituated great apes but also human populations 
in contact with wild great apes, providing enormous benefits to both human and wild animal health.
Material and Methods
Sampling. Necropsies on chimpanzees were conducted under high safety standards and precautions such as 
protection suits, gloves, and face masks were used to avoid contamination of samples with human pathogens. At 
LWC pharyngeal swabs were collected from six animals under sedation. All samples were preserved in RNAlater 
(LWC) or liquid nitrogen (TNP) and shipped to Germany for detailed analyses. No experiments on live animals 
were performed for this study, samples were collected from animals found dead or sedated for treatment neces-
sary to save their lives, and therefore no animal ethics permission is required according to the national laws of 
Ivory Coast and Cameroon.
Histology. Tissue samples from five of the six deceased chimpanzees from TNP on which necropsies had 
been performed, and from the deceased chimpanzee from LWC were submitted to the German Primate Centre 
(Göttingen, Germany) for histopathological examination. All samples were fixed in 4% formalin, embedded in par-
affin, cut in 2–4 µm tissue sections and stained with hematoxylin and eosin for microscopic examination. Tissue was 
also stained with Giemsa and Gram stain and to visualize fungal infection furthermore PAS reaction was performed.











South Group 2009 86% 6*/37
Lung tissue 
(n = 6)












negative Type A2 Positive not tested not tested









Type B negative Positive not tested not tested
Group 3 2007 100% 1/4
Lung tissue 
(n = 1)
Type B negative Positive not tested
accomplished 
(n = 1; ST 8949)
Table 1. Characteristics and analyses of respiratory disease outbreaks among chimpanzees in Taï National Park 
(Côte d’Ivoire) and Limbe Wildlife Center (Cameroon). *Refers to the number of individuals where necropsies 
had been performed. Further five animals were found dead but necropsies were not performed due to the 
destruction of the carcass by scavengers or logistical reasons. Additionally three animals disappeared during the 
outbreak and are considered victims of the epidemic. n.s. not sampled.
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DNA/RNA extraction and cDNA synthesis. Nucleic acids from lung tissue were extracted using the 
Nucleo Spin Tissue - and Nucleo Spin RNA II Kit (Macherey-Nagel, Düren, Germany), according to the man-
ufacturer’s instructions. Swab samples stored in RNAlater were vortexed vigorously and RNA and DNA were 
extracted simultaneously from 280 µl of RNAlater using the QIAamp viral Mini Kit (Qiagen, Hilden, Germany). 
cDNA was synthesized by using the Superscript Kit (Invitrogen, Karlsruhe, Germany) and random hexamer 
primers (TIB Molbiol, Berlin, Germany).
PCR screening for respiratory pathogens and phylogenetic analysis. DNA or cDNA respectively 
were screened for influenza A&B, HMPV, HRSV, Adeno-, Picornavirus and S. pneumoniae using PCR assays as 
described previously35–40. For phylogenetic analysis, the G gene of HMPV or HRSV was amplified using pub-
lished PCR assays17,41 PCR products were purified using ExoSAP (USB Europe GmBH, Staufen, Germany) and 
sequenced subsequently using the ABI Big Dye Termination Kit (Applied Biosystems, Weiterstadt, Germany). 
Phylogenetic analyses of the paramyxovirus sequences were performed in a Bayesian framework. First, data sets 
were assembled that comprised one exemplary sequence per outbreak (-year) generated in this study (see supple-
mentary information for details) and human HMPV or HRSV G gene sequences extracted from publicly availably 
full genomes with known isolation dates (retrieved from NCBI). Both data sets were aligned using MUSCLE42, as 
implemented in SeaView, version 443, and reduced to only include unique sequences using FaBox44. Conserved 
alignment blocks were selected using gblocks (also implemented in SeaView). Three final alignments were gener-
ated: HMPV with 129 sequences and 711 positions, HRSV-A with 284 sequences and 968 positions and HRSV-B 
with 139 sequences and 954 positions. To determine the appropriate nucleotide substitution model, we estimated 
model likelihoods with jModeltest v2.1.1045 and compared them using the Bayesian information criterion (BIC). 
The selected models were GTR + G for HMPV, GTR + I + G for HRSV-A and HKY + G for HRSV-B. Bayesian 
analyses were run in BEAST v1.8.246 assuming a longnormal-relaxed clock and a constant population size. Three 
chains were run for 100 million generations; convergence of the runs and appropriate sampling of the posterior 
were assessed using Tracer v1.647. Post burn-in trees from the three chains were combined using LogCombiner 
v1.8.2 before being summarized onto the maximum clade credibility tree identified with TreeAnnotator v1.8.2 
(both software programs are distributed with BEAST). Branch robustness was assessed through posterior 
probabilities.
16s rDNA Libraries from lung tissues. For a first screening for relevant bacteria, DNA from lung tissue 
samples from the TNP cases were tested using a 16s PCR48. Insufficient material was available for these analyses 
to be performed on the samples from the LWC infant. Amplicons were cloned into a pCR™ 2.1-TOPO® vector 
(Invitrogen, Karlsruhe, Germany) and colony PCR was performed on ten different clones (per sample) using M13 
primers. PCR products were purified using ExoSAP (USB Europe GmBH, Staufen, Germany) and sequenced 
using the ABI Big Dye Termination Kit (Applied Biosystems, Weiterstadt, Germany). Sequences were compared 
to sequences contained in Genbank using the BLAST algorithm (http://blast.ncbi.nlm.nih.gov/Blast.cgi).










Table 2. Resistance pattern of pneumococcus isolates present in lung tissue of deceased TNP chimpanzees 
(adults 1 and 2).
Isolate/DNA sample (country of origin)
Allel number for gene fragment
ST SerotypearoE gdh gki recP spi xpt ddl
IMT113/115 (TNP, Côte d’Ivoire) 7 11 4 1 6 112 8 8485* 19 A
107 isolates (Kenia and Gambia) 7 11 4 1 6 112 14 847 19 A
PVT0032 (Gambia) 7 11 4 1 6 112 15 3326 19 A
LWC infant (LWC, Cameroon) 177 134 4 18 9 83 18 8949 n.d.
KSA08 (Chad) 177 134 4 18 9 83 18 8949 9 V
Table 3. Allelic profile of S. pneumoniae originating from chimpanzee lung tissue compared to closely related 
human isolates from the MLST data base. Samples analysed in this study are written in bold. n.d. not detected. 
*New ST.
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Characterization of S. pneumoniae. Isolation. Lung tissue preserved in STGG had been collected from 
TNP adult 1 and 2 and was streaked on tryptic soy yeast extract (TSYE) agar supplemented with 5% of defi-
brinated sheep blood (Oxoid, Wesel, Germany) and incubated overnight in 5% CO2. S. pneumoniae was identified 
by colony morphology, α-hemolysis and optochin sensitivity and confirmed by PCR analysis as described below. 
Isolates from TNP adult 1 are registered under the number IMT 113 and the ones from TNP adult 2 as IMT 115.
Antimicrobial susceptibility testing. Antimicrobial susceptibility testing was performed using the agar diffusion 
test according to the standards given by the Clinical and Laboratory Standards Institute49,50. The antimicrobial 
agents tested included chloramphenicol (30 µg), clindamycin (2 µg), oxacillin (1 µg, sulfamethoxazole/trimeth-
oprime (1, 25/23, 75 µg), tetracycline (30 µg), enrofloxacin (5 µg), erythromycin (15 µg), clarithromycin (15 µg) 
vancomycin (30 µg) (Becton Dickinson, Heidelberg, Germany).
Multi Locus Sequence Typing (MLST). For MLST analysis, DNA was extracted from overnight cultures (TNP 
isolate IMT 113 and 115) or directly from lung tissue from the LWC sample using the Nucleo Spin Tissue Kit 
(Macherey & Nagel, Stadt, Land) according to the manufacturer’s instructions. PCR analyses were performed 
using standard primers and protocols given on the Streptococcus pneumoniae MLST website (http://pubmlst.
org/spneumoniae) using a proof reading polymerase (Promega, Berlin, Germany). PCR fragments of the seven 
housekeeping genes adh, gdh, gki, spi, recP, xpt and ddl were obtained for all samples.
Amplicons from the TNP isolates were purified directly using ExoSAP (USB Europe GmBH, Staufen, 
Germany) and sequenced using the ABI Big Dye Termination Kit (Applied Biosystems, Weiterstadt, Germany). 
For the sample from LWC (DNA from lung tissue instead of a pure culture) MLST results were generated based on 
“virtual clones”: to minimize the possibility that two or multiple pneumococcus strains were involved, each of 
the seven amplicons was cloned into a pCR™ 2.1-TOPO® vector (Invitrogen, Karlsruhe, Germany). For every 
cloning reaction, ten clones were picked and colony PCR was performed using M13 primers. PCR products 
were purified and sequenced as described above. For every allele, sequences were checked for consistency using 
Genious version 7.1.4 (http://www.geneious.com)51.
Sequences obtained were entered in the MLST database and allelic numbers were assigned (all alleles were 
already present in the database). Since the TNP isolates showed a new allelic combination i.e. differed in one locus 
(ddl), a new ST was assigned by the curator (Table 2).
Serotyping PCR. Serotyping was done by PCR according to Pai et al.27. However, due to a shortage of DNA mate-
rial, we did not follow the sequential multiplex PCR assay described, but rather chose serotype specific primers 
according to the serotype information given for human strains in the MLST database that matched our clones the 
most. DNA from TNP bacterial isolates were tested using the primers specific for capsule type 19 A. DNA from 
the LWC lung sample was tested for serotype 9 V but tested negative. In addition a 9 V/9 A primer combination 
described by Carvalho et al.28 was tried however the DNA tested negative. Further serotype testing was not pos-
sible due to a lack of DNA.
Data availability. The datasets generated and analysed during the current study are available from the cor-
responding author on request.
Accessions code. Sequences data on the HRSV and HMPV strains are available in Genbank under the acces-
sion number JX489496 - JX489498.
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